Related Experiment Video

Updated: Jul 26, 2026

Measurement of γHV68 Infection in Mice
13:22

Measurement of γHV68 Infection in Mice

Published on: November 22, 2011

14.0K

Letter to the Editor: HBV DNA level of genuine immune-tolerant patients

Chia-Ming Chu1, Yun-Fan Liaw

  • 1Liver Research Unit, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taipei, Taiwan.

Hepatology (Baltimore, Md.)
|December 2, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

3.4K
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.7K

Related Experiment Videos

Last Updated: Jul 26, 2026

Measurement of γHV68 Infection in Mice
13:22

Measurement of γHV68 Infection in Mice

Published on: November 22, 2011

14.0K
Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

3.4K
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.7K

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Articles linked to this work by shared authors, journal, and citation graph.

Switching to Entecavir >3 Months Before the End of Tenofovir-Based Therapy in Hepatitis B e Antigen-Negative Patients May Reduce Early Relapse and Hepatitis Flare.

The American journal of gastroenterology·2025

Finite nucleos(t)ide analog therapy for functional cure in HBeAg-negative chronic hepatitis B: Recent development in the paradigm shift.

Hepatology (Baltimore, Md.)·2024

Hepatocellular Carcinoma with Gastric Metastasis Mimicking a 4 cm Gastrointestinal Stromal Tumor After a 3-year Disease-free Interval.

Journal of clinical and translational hepatology·2024

Higher end-of-treatment HBsAg levels is associated with later onset but not severe relapse in HBeAg-negative chronic hepatitis B patients stopping antivirals.

Alimentary pharmacology & therapeutics·2024

Hepatocellular carcinoma reduced, HBsAg loss increased, and survival improved after finite therapy in hepatitis B patients with cirrhosis.

Hepatology (Baltimore, Md.)·2023

Autoimmune hepatitis and primary biliary cholangitis are among a subset of autoimmune diseases defined by profound co-prevalence and genetic risk association with the IL12 pathway.

Hepatology (Baltimore, Md.)·2026

Adjuvant pegylated interferon-alpha after nucleos(t)ide analog withdrawal drives a temporally coordinated expansion of regulatory B cells and contraction of HBV-specific T cells.

Hepatology (Baltimore, Md.)·2026

An international multicenter analysis of the outcome of pediatric first variceal hemorrhage.

Hepatology (Baltimore, Md.)·2026

AASLD EXPO: Liver biopsy.

Hepatology (Baltimore, Md.)·2026

Efficacy and safety of an 8-week bemnifosbuvir and ruzasvir regimen in chronic hepatitis C: Results from a Phase 2 study.

Hepatology (Baltimore, Md.)·2026

TESERA: morphologic subtyping and prognostic stratification of hepatocellular carcinoma from H&E whole-slide images.

Hepatology (Baltimore, Md.)·2026

X-linked hyper IgM syndrome with a novel CD40-ligand gene mutation suffered from infection of Talaromyces marneffei.

Frontiers in immunology·2026

Intravitreal Anti-vascular Endothelial Growth Factor Injection Practices Among Indonesian Vitreoretinal Specialists: Findings From a 2021 National Survey.

Cureus·2026

A narrative review of barrier-matched engineering of macrophages for solid tumor immunotherapy: design logic, translational barriers and clinical outlook.

Translational cancer research·2026

Comparison of the efficacy of TXNDC5 monoclonal antibody versus conventional drugs in the treatment of intestinal fibrosis associated with inflammatory bowel disease.

Journal of molecular histology·2026

Tumor-targeted IL-10 synergizes with IL-2 to enhance antitumor immunity while minimizing immune-related adverse events.

Nature communications·2026

When Should Ileal Pouch-Anal Anastomosis Be Performed After Inpatient Total Abdominal Colectomy for Acute Medically Refractory Ulcerative Colitis? Experience of 274 Consecutive Patients.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us